Anti-Annexin V/ANXA5 antibody [EPR3979]
- KO Validated
- RabMAb
- Recombinant
- What is this?
3
(4 Reviews)
|
(7 Publications)
Rabbit Recombinant Monoclonal Annexin V/ANXA5 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 7 publications.
View Alternative Names
ANX5, ENX2, PP4, ANXA5, Annexin A5, Anchorin CII, Annexin V, Annexin-5, Calphobindin I, Endonexin II, Lipocortin V, Placental anticoagulant protein 4, Placental anticoagulant protein I, Thromboplastin inhibitor, Vascular anticoagulant-alpha, CPB-I, PAP-I, VAC-alpha
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Annexin V/ANXA5 antibody [EPR3979] (AB108321)
Immunohistochemical analysis of Annexin V/ANXA5 in paraffin embedded Human gastric tissue using ab108321 at a 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-Annexin V/ANXA5 antibody [EPR3979] (AB108321)
All lanes:
Western blot - Anti-Annexin V/ANXA5 antibody [EPR3979] (ab108321) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
JAR cell lysate at 10 µg
Lane 3:
fetal kidney lysate at 10 µg
Predicted band size: 35 kDa
false
- WB
Lab
Western blot - Anti-Annexin V/ANXA5 antibody [EPR3979] (AB108321)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : Annexin V/ANXA5 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lanes 1 - 3 : Merged signal (red and green). Green - ab108321 observed at 35 kDa. Red - loading control, ab18058, observed at 130 kDa.
ab108321 was shown to specifically react with Annexin V/ANXA5 in wild-type cells as signal was lost in Annexin V/ANXA5 knockout cells. Wild-type and Annexin V/ANXA5 knockout samples were subjected to SDS-PAGE. ab108321 and ab18058 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Annexin V/ANXA5 antibody [EPR3979] (ab108321)
Predicted band size: 35 kDa
false
- WB
Lab
Western blot - Anti-Annexin V/ANXA5 antibody [EPR3979] (AB108321)
Western blot : Anti-ANXA5 antibody [EPR3979] (ab108321) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab108321 was shown to bind specifically to ANXA5. A band was observed at 36 kDa in wild-type A549 cell lysates with no signal observed at this size in ANXA5 knockout cell line. To generate this image, wild-type and ANXA5 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Annexin V/ANXA5 antibody [EPR3979] (ab108321) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
Western blot - Human ANXA5 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-anxa5-knockout-a549-cell-line-ab300840'>ab300840</a>)
Lane 2:
ANXA5 knockout A549 cell lysate at 20 µg
Secondary
Lanes 1 - 2:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 2:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 36 kDa
false
Related conjugates and formulations (1)
-
Anti-Annexin V/ANXA5 antibody [EPR3979] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Annexin V has an important role in cell membrane dynamics and signaling. The protein does not function as part of a larger complex but its ability to bind negatively charged phospholipids like phosphatidylserine makes it important in apoptosis. During apoptosis phosphatidylserine translocates to the outer leaflet of the plasma membrane where annexin V marks these apoptotic cells. This property enables annexin V-based assays to detect early stages of apoptosis.
Pathways
Annexin V involvement is seen in pathways associated with blood coagulation and apoptosis. In the apoptosis pathway annexin V interacts with apoptotic markers to identify dying cells. It relates to proteins such as caspases which are key executors of apoptosis. In coagulation annexin V has been shown to interact with prothrombinase complex and can affect calcium ion concentration thereby influencing blood clotting processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Journal of medicinal chemistry 65:16432-16450 PubMed36459180
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 23:123 PubMed35261637
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 25: PubMed34878150
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 10:1717 PubMed33014851
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:5923 PubMed32246062
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 14:180 PubMed27317346
2016
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 7:e44701 PubMed22970290
2012
Applications
WB, IHC-P
Species
Human, Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com